Clinical Outcome Assessment of Parkinson’s Disease Patients Treated With XADAGO (Safinamide)
Condition(s):Idiopathic Parkinson DiseaseLast Updated:July 13, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Idiopathic Parkinson DiseaseLast Updated:July 13, 2021Completed
Condition(s):Parkinson DiseaseLast Updated:October 11, 2019Completed
Condition(s):Idiopathic Parkinson’s Disease (at Later Stage)Last Updated:April 29, 2020Unknown status
Condition(s):HealthyLast Updated:August 1, 2017Completed
Condition(s):Multiple System AtrophyLast Updated:October 13, 2021Completed
Condition(s):HealthyLast Updated:April 15, 2016Completed
Condition(s):Parkinson DiseaseLast Updated:September 18, 2017Terminated
Condition(s):Parkinson DiseaseLast Updated:September 23, 2021Completed
Condition(s):HealthyLast Updated:August 25, 2021Completed
Condition(s):Parkinson’s DiseaseLast Updated:March 29, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.